NIH Marks $275M for Rare Disease and Extracellular RNA Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health has pledged $275 million to fund two multi-year research programs, including studies to discover the causes and cures for rare diseases and how extracellular RNA is involved in disease, NIH said today.

The new strategic funding from NIH's Common Fund includes $145 million for the Undiagnosed Diseases Program, or UDP, and $130 million for the Extracellular RNA Communication program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.